# Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)

> **NCT02566811** · NA · TERMINATED · sponsor: **University College, London** · enrollment: 49 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** Abdominal surgery
- **PROCEDURE:** Lymphadenectomy

## Key facts

- **NCT ID:** NCT02566811
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-12
- **Primary completion:** 2019-08-14
- **Final completion:** 2019-08-14
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Withdrawal of funding by CR UK due to poor recruitment
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566811, "Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02566811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*